Frontlight ResearchEarly access
Trial site
Szpital Specjalistyczny Im. Jedrzeja Sniadeckiego W Nowym Saczu SPZOZ
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Myeloproliferative neoplasms2 trials
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Immune thrombocytopenia (ITP)1 trial
- Multiple myeloma1 trial
- Phase
- Phase 34 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- argenx1 trial
- Enliven Therapeutics1 trial
- GlaxoSmithKline1 trial
- Kartos Therapeutics Inc.1 trial
- Merck Sharp & Dohme LLC1 trial
- and 1 more
Running trials
Recruiting
Recruiting
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Recruiting
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic myeloid leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Immune thrombocytopenia (ITP)1 recruiting
- Myeloproliferative neoplasms1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026